Hi Fruitb2,
Good discussion around the GVHD application.
My understanding is that the cost of treating a child is around US$1m .
Eddison (research note 27/5/14) estimate the reimbursement price is at US$100k (the States) & $75K (Europe). Our CEO (Feb15) recently stated that reimbursement price in US /Japan could be somewhere b/w US$250k- $500k per treatment.
As we are aware , an FDA approved 60 pediatric patients trial with aGVHD, is in progress.
Lets hope it all goes to plan.
Speculation on Japanese revenue stream, page-16
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.08 | $5.380M | 4.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 69437 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 19999 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |